LILRB2 and B-cell chronic lymphocytic leukemia: Within malignancies, enrichment of LILRB2 is often noted, including in AML, chronic lymphocytic leukemia (CLL), esophageal cancer, pancreatic cancer, NSCLC, and lobular breast cancers [427].